| 英文名称 |
中文名称 |
CAS号 |
操作 |
| Pranlukast Impurity 2 |
普仑司特杂质2 |
211116-98-2 |
详细
|
| Orphenadrine EP Impurity C HCl |
盐酸苯海拉明杂质C |
1808-12-4 |
详细
|
| Sacubitril Valsartan Impurity 2-07 |
沙库巴曲缬沙坦杂质2-07 |
2459446-57-0 |
详细
|
| Mavacamten Intermediate II Impurity 1 |
玛伐凯泰中间体Ⅱ杂质1 |
66400-12-2 |
详细
|
| Tenofovir Impurity O |
替诺福韦杂质O |
1217630-57-3 |
详细
|
| LTT-Y-854054, the isomer of Letastine |
立他司特异构体LTT-Y-854054 |
2271299-08-0 |
详细
|
| Propofol Impurity V |
丙泊酚杂质V |
494-72-4 |
详细
|
| Propofol Impurity H |
丙泊酚杂质H |
5534-18-9 |
详细
|
| Propofol Impurity XII |
丙泊酚杂质XII |
35946-91-9 |
详细
|
| Ibrutinib initiator I impurity A cyclic dimeric impurity derived impurity 2 |
伊布替尼起始物I杂质A成环二聚杂质衍生杂质2 |
|
详细
|
| Ibrutinib initiator I impurity A cyclic dimeric impurity derived impurity 1 |
伊布替尼起始物I杂质A成环二聚杂质衍生杂质1 |
|
详细
|
| Mabaloxavir Impurity 2 |
玛巴洛沙韦杂质2 |
|
详细
|
| L-Alaninamide, N-[(1,1-dimethylethoxy)carbonyl]-L-alanyl- (9CI) |
L-Alaninamide, N-[(1,1-dimethylethoxy)carbonyl]-L-alanyl |
41036-24-2 |
详细
|
|
（1S，2S）-2-（（（2,4-二甲基嘧啶-5-基）氧基）甲基）-2-（3-氟苯基）-N-（5-氟吡啶-2-基）环丙烷-1-甲酰胺 |
3070371-43-3 |
详细
|
|
(1R，2S)-N-(5-氯吡啶-2-基)-2-[[(2,4-二甲基嘧啶-5-基)氧]甲基]-2-(3-氟苯基)环丙烷-1-甲酰胺（莱博雷生杂质31） |
|
详细
|
| (2S,3S)-2,3-bis(benzoyloxy)succinic acid |
D-二苯甲酰酒石酸 |
17026-42-5 |
详细
|
| E-configuration ceftazidime side chain acid active ester |
E构型-头孢他啶侧链酸活性酯 |
|
详细
|
| 5-Chloro-N-[4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)-1,3-thiazol-2-yl]-6-(dimethylamino)pyridine-3-carboxamide (AFQBP-IM-A) |
5-氯-N- [4-(4-氯噻吩-2-基)-5-(4-环己基哌嗪-1-基)-1,3-噻唑-2-基]-6-(二甲氨基)吡啶-3-甲酰胺（AFQBP-IM-A) |
|
详细
|
| 1-(3-chloro-5-{[4-(5-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)-1,3-thiazol-2-yl]carbamoyl}pyridin-2-yl)piperidine-4-carboxylic acid (AFQBP-IM-C) |
1-(3-氯代-5-｛[4-(5-氯噻吩-2-基)-5-(4-环己基哌嗪-1-基)-1,3-噻唑-2-基]氨基甲酰基｝吡啶-2-基)哌啶-4-羧酸（AFQBP-IM-C) |
|
详细
|
| N-Nitrosovildagliptin amide |
N-亚硝基维格列汀酰胺 |
|
详细
|